Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||
| Net Income | -3,350 | -7,650 | -1,920 |
| Depreciation Amortization | 67 | 200 | 40 |
| Other Working Capital | -697 | 530 | 140 |
| Other Operating Activity | 516 | 960 | 90 |
| Operating Cash Flow | $-3,464 | $-5,960 | $-1,650 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -556 | -510 | -750 |
| Other Investing Activity | 0 | 0 | -50 |
| Investing Cash Flow | $-556 | $-510 | $-800 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 0 | 15,000 | 8,860 |
| Financing Cash Flow | $N/A | $15,000 | $8,860 |
| Beginning Cash Position | 14,926 | 6,400 | 0 |
| End Cash Position | 10,906 | 14,920 | 6,400 |
| Net Cash Flow | $-4,020 | $8,520 | $6,400 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,464 | -5,960 | -1,650 |
| Capital Expenditure | -556 | N/A | N/A |
| Free Cash Flow | -4,020 | -5,960 | -1,650 |